Sign in

Multiple Myeloma Research Foundation (MMRF)

@themmrf.bsky.social
416 followers 53 following 101 posts

We are the largest nonprofit in the world solely focused on accelerating a cure for each and every multiple myeloma patient. themmrf.org

PostsRepliesMedia
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 18/09/2025
Day 1 at #IMS2025 is in the books! The MMRF team is on the ground in Toronto, bringing you insights from the world’s largest myeloma meeting. From new therapies to strategies for high-risk patients, see our recap of day 1: 👉 themmrf.org/mmrf-blogs/i...
themmrf.org
IMS Annual Meeting - Day 1 - MMRF
This week, the International Myeloma Society (IMS) is hosting its 22nd Annual Meeting—the world’s largest gathering of multiple myeloma researchers and clinicians. The MMRF team is on the ground in To...
020
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 17/09/2025
Tecvayli is approved for later line therapies in relapsed/refractory patients. However, studies at #IMS2025 are highlighting the impact bispecifics like Tecvayli can have for newly diagnosed patients. Efficacy results are still very early, but encouraging.
030
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 17/09/2025
Can we amend diagnostic criteria to help identify high risk smoldering patients? Dr. Sagar Lonial weighs in how circulating tumor cells could factor into these criteria #IMS2025
000
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 17/09/2025
#IMS2025 kicks off with a promising stat—in 2025, there are currently 300+ myeloma papers published per month! This highlights the importance of the organizations like @theMMRF in expanding research efforts that increase options for #myeloma patients.
032
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 28/07/2025
Blenrep has been approved in both the EU 🇪🇺 and Canada 🇨🇦—a meaningful step toward broader global access for myeloma patients. In the U.S., the FDA review continues. Here’s what patients should know: themmrf.org/mmrf-blogs/t... #MultipleMyeloma #Blenrep #MMRF
themmrf.org
The State of Blenrep: What Patients Should Know - MMRF
Updated 7/25/2025 Blenrep (belantamab mafodotin) has now been approved for use in both the European Union and Canada—clear signals that international health authorities recognize its clinical value an...
011
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 23/07/2025
The FDA has delayed its decision on Blenrep. The MMRF remains hopeful and continues to support approval. Blenrep offers real potential for patients who need accessible, effective care. Learn more: themmrf.org/mmrf-blogs/t... #MultipleMyeloma #Blenrep #MMRF #FDA
themmrf.org
The State of Blenrep: What Patients Should Know - MMRF
Updated 7/23/2025 The FDA has announced a delay in its decision on Blenrep (belantamab mafodotin), signaling that more time is needed to complete its review. The deadline for approval is October 23, 2...
011
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 22/07/2025
The MMRF weighs in on the latest Blenrep (belantamab mafodotin) news and what it means for patients. With the FDA's decision pending, we’re closely watching next steps. Stay informed and read more 👉 themmrf.org/mmrf-blogs/t... #MultipleMyeloma #Blenrep
themmrf.org
The State of Blenrep: What Patients Should Know - MMRF
The MMRF supports FDA approval of Blenrep (belantamab mafodotin) as a meaningful treatment option for patients with relapsed/refractory multiple myeloma. In the coming days, the FDA will decide whethe...
020
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 17/07/2025
The FDA’s ODAC voted against the current benefit-risk profile of #Blenrep. Approval of this novel therapy is still pending. The MMRF continues to champion safety, equitable access, shared decision-making & team-based care in the development of new #myeloma therapies.
000
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 16/07/2025
Having the right tests is important: they help your doctor confirm a diagnosis, assess the extent of your disease, & monitor progress once you start treatment. Download our Learn Your Labs booklet to better understand the blood tests used in myeloma care: themmrf.org/educational-...
100
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 14/07/2025
⏰ URGENT: July 15 deadline approaching! #Myeloma patients are running out of options. The MMRF is the only organization solely dedicated to drug discovery and development for these patients. Your donation today will help extend lives. give.themmrf.org/campaign/687... #MMRF #CancerResearch
010
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 11/07/2025
The FDA just approved a new #Elrexfio dosing schedule. Patients who achieve a sustained response after a set time can now dose every 4 weeks — a shift from the previous standard of biweekly dosing. This is a meaningful step toward reduced treatment burden in #MultipleMyeloma.
021
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 11/07/2025
The MMRF's Dr. Chuck Acharya will present at the 3rd Annual IMS Workshop on Genomics: 📌 Mapping the interplay between tumor & immune microenvironment – insights from the Immune Atlas Consortium 📅 Jul 12, 9 AM (Lisbon, Portugal) 🔗 Register here: ow.ly/xJct50Wo2fC
ow.ly
3rd Annual Workshop on Genomics - International Myeloma Society
Registration Rates In Person Registration Admission to scientific sessions. Admission to breakfasts, lunches, and coffee breaks. Certificate of attendance. One-year access to on-demand session recordi...
000
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 03/07/2025
Curious about the latest research in #myeloma treatment? Dr. @FaithEDavies1 & Dr. @OmarNadeemMD break down key updates from #ASCO25 and #EHA2025 during our Patient Livestream on 7/9 at 3pm ET. RSVP here: www.facebook.com/events/14846... #mmsm
facebook.com
FAQs on Myeloma Updates from ASCO & EHA 2025
Other event by Multiple Myeloma Research Foundation - MMRF on Wednesday, July 9 2025
011
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 02/07/2025
@fda.gov approves bispecific antibody, Lynozyfic (linvoseltamab), for treatment of relapsed/refractory #myeloma patients who have received 4 prior lines of therapy. investor.regeneron.com/news-release... Learn more about LINKER-MM1 study. themmrf.org/mmrf-blogs/e...
investor.regeneron.com
Lynozyfic™ (linvoseltamab-gcpt) Receives FDA Accelerated Approval for Treatment of Relapsed or Refractory Multiple Myeloma | Regeneron Pharmaceuticals Inc.
TARRYTOWN, N.Y. , July 02, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for...
030
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 01/07/2025
🚨 Calling early-career researchers! The 2025 MMRF Scholars Program is now accepting applications. $400K over 4 years for rising stars in myeloma research. 🧬 Apply by 9/30. 🔗 ow.ly/uz4P50WjfTv #theMMRF #Myeloma #ResearchFunding #CancerResearch
020
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 27/06/2025
The FDA’s removal of REMS for CAR T therapy is a big step forward—improving access for #myeloma patients, especially in rural and underserved areas. It lowers barriers to care and expands access to next-generation CAR T therapies and treatment combinations. #HealthEquity
033
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 16/06/2025
This past weekend, Dr. Chuck Acharya, Associate Director of Translational Research at the MMRF, presented at #EHA2025: 🧬 Immunomodulatory Effects of Daratumumab-Based Therapy in FHRMM Patients (MyDRUG Trial) 📅 June 14
000
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 16/06/2025
📚 NEW CME/CE/CNE Activity for Healthcare Providers In this free interactive activity, MMRF Chief Medical Officer Dr. Hearn Jay Cho summarizes key evidence on approved and emerging treatments for relapsed/refractory #myeloma. Claim your credit today: www.mycme.com/courses/trea...
mycme.com
myCME | Continuing Medical Education
Free online CME & CE for physicians, nurse practitioners, physician assistants & other healthcare professionals in primary care, cardiology, oncology, and other specialties.
000
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 10/06/2025
TOMORROW: Don't miss our Patient Livestream! Dr. Cindy Varga, PA Jordan Robinson, and a #myeloma patient will answer your questions & share real-life experiences with bispecific antibodies. Set a reminder: www.facebook.com/events/10294... #mmsm
011
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 09/06/2025
Feeling overwhelmed by your #myeloma journey? You're not alone. Whether you’re smoldering, newly diagnosed, or relapsed/refractory, our mentors are here to offer guidance & share real-life experiences. Connect with a mentor: themmrf.org/support/myel...
022
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 05/06/2025
Wondering what bispecific antibody therapy is like? Join Dr. Cindy Varga, PA Jordan Robinson, & a #myeloma patient as they share real experiences & answer your questions. 📅 Live on Facebook! 👍 Mark "Interested" or "Going" on our event page: www.facebook.com/events/10294...
021
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 04/06/2025
Day 2 at #ASCO25 delivered more promising updates for #myeloma patients including 5-year cancer-free results from CAR T-cell therapy, a potential new option with trispecific antibodies, a new way to give Sarclisa, and more. Read all the highlights here: themmrf.org/mmrf-blogs/m...
themmrf.org
MMRF at ASCO 2025: Day 1 – What Patients Should Know - MMRF
We’re excited to share highlights from the first day of the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, one of the year’s most important events in cancer research. This year, res...
020
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 04/06/2025
Key takeaways are now available from Day 1 of the #ASCO25 Annual Meeting 🔬. Explore our latest blog to learn about promising updates on Blenrep, advances in treatment for newly diagnosed high-risk #myeloma patients, and more: themmrf.org/mmrf-blogs/m...
themmrf.org
MMRF at ASCO 2025: Day 1 – What Patients Should Know - MMRF
We’re excited to share highlights from the first day of the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, one of the year’s most important events in cancer research. This year, res...
021
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 03/06/2025
Can some of the limitations of bispecifics be overcome by introducing them in earlier lines of therapy? Dr. Attaya @suvannasankha weighs in on early data coming out of clinical trials testing bispecific combinations in newly diagnosed #myeloma patients. #ASCO2025
020
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 03/06/2025
Dr. Evangelos Terpos discusses extending dose intervals with Belamaf to avoid ocular side effects while still preserving clinical response in older #myeloma patients. #ASCO25
042
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 03/06/2025
New therapies discussed at #ASCO25, including a trispecific antibody tested in relapsed/refractory patients.
041
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 01/06/2025
Continuing the MRD discussion at #ASCO25 — Drs. Ben Derman, Luciano Costa, Rebecca Silbermann, and Neha Korde share thoughts MRD based treatment decisions for patients and the future of integrating MRD across clinics.
020
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 29/05/2025
📚 NEW CME/CE for HCPs Relapsed/refractory #myeloma remains a treatment challenge, but new options like CAR T-cell therapy & bispecifics are shifting the landscape. Learn from leading experts in this FREE accredited activity. Claim your credit today: ce.paradigmmc.com/a/BXWSSW
031
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 28/05/2025
After losing his daughter to breast cancer, Randy faces his own battle with myeloma. 7 years later, he finally heard the word many patients never get to: remission. His story is one of resilience & hope. Watch now. Together, we will cure #myeloma. ❤️ youtu.be/lfGY4esaQZA
youtu.be
MMRF Patient Stories: Randy
YouTube video by Multiple Myeloma Research Foundation - MMRF
042
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 27/05/2025
It's not too late to sign up for our webinar happening TOMORROW at 12pm ET/9am PT! Join us to learn how bispecific antibodies work, the benefits they offer, potential side effects, & what patients can expect during treatment. Learn more & register here: event.webcasts.com/starthere.js...
000
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 21/05/2025
The future of multiple #myeloma treatment depends on what we do NOW. The MMRF is investing in bold science, breaking down data silos, and pushing for equity – so the next decade outpaces the last. CEO Michael Andreini explains: themmrf.org/mmrf-blogs/i...
themmrf.org
Is Progress in Multiple Myeloma Stalling? - MMRF
By Michael Andreini, President and CEO, Multiple Myeloma Research Foundation   Twenty-six years ago, when the Multiple Myeloma Research Foundation® (MMRF) was started, a multiple myeloma diagnosis was...
052
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 21/05/2025
Horizon builds on our commitment to ensure that our research initiatives are representative of the real-world #myeloma patient population and inclusive of experiences that have not historically been reflected in research. Read our 2024 Donor Impact Report: themmrf.org/about/financ...
010
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 16/05/2025
Mark your calendars! You're invited to a 1-hour webinar where we'll talk about bispecific antibody therapy, an immunotherapy that helps the immune system recognize and destroy #myeloma cells. Don’t miss out—register now: event.webcasts.com/starthere.js...
010
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 15/05/2025
The MIF is the only mission-driven venture philanthropy fund focused on a cure for #myeloma. We invest in early-stage biotech companies developing innovative treatments that could be life-changing. Explore our portfolio: www.myelomainvestmentfund.org/portfolio/ #NationalCancerResearchMonth
032
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 13/05/2025
Join us tomorrow for a live Q&A with Dr. Jodi Lipof & nurse practitioner Samantha Shenoy from @ucsfcancer.bsky.social, as they answer questions on CAR T-cell therapy. Plus, hear from a #myeloma patient about her experience with this treatment. Set a reminder here: www.facebook.com/events/12455...
021
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 12/05/2025
🔬 1,100+ #myeloma patients. 10+ years of data. The largest clinical-genomic study of its kind: the MMRF CoMMpass℠ Study. It's supported 100+ peer-reviewed papers, and countless abstracts & presentations worldwide. Learn more: themmrf.org/finding-a-cu... #NationalCancerResearchMonth
020
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 09/05/2025
The wait is almost over! Our MMRF Patient Summit, in partnership with @cityofhope.bsky.social, is happening TOMORROW. If you can’t make it in-person you can join virtually at 9am ET. Register now so you don’t miss out: event.webcasts.com/starthere.js...
021
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 08/05/2025
Healthcare professionals in the myeloma field, don’t miss out! In this CME-accredited activity, experts in hematology discuss the use of bispecific antibodies for relapsed/refractory #myeloma. 🎓 Earn your credit today: d.answersincme.com/160203294_2/...
d.answersincme.com
MDADI
MDADI
021
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 06/05/2025
This #NationalNursesDay, we would like to thank nurses for the comfort & compassion they offer when we need it most. Special shoutout to our MMRF Patient Navigators, former oncology professionals supporting myeloma patients at every step. Drop a ❤️ to thank nurses everywhere!
042
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 05/05/2025
🚨 Hurry! Secure your spot for our informative & interactive MMRF Patient Summit in partnership with @cityofhope.bsky.social. Discover the latest treatment strategies for newly diagnosed & relapsed/refractory #myeloma, managing symptoms & side effects, and more: event.webcasts.com/starthere.js...
110
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 01/05/2025
May is #NationalCancerResearchMonth 🔬 At the MMRF, we’re advancing new therapies, optimizing current treatments & improving care for every patient. Since 1998, the 5-year survival rate has risen from 34.6% to 61.1%. See how we’re getting closer to a cure: themmrf.org/finding-a-cu...
052
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 30/04/2025
📅 Mark your calendars! Don’t miss out on the MMRF Patient Summit in partnership with @cityofhope.bsky.social. This is your chance to engage with top #myeloma specialists, learn practical tips for managing symptoms & side effects, and more! Secure your spot: event.webcasts.com/starthere.js...
151
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 29/04/2025
⌛It’s almost time! Our webinar on CAR T-cell therapy is happening TOMORROW. Join us to learn about how this treatment works, how it's given to patients, and key side effects to be aware of. We hope to see you there—register now: event.webcasts.com/starthere.js...
011
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 25/04/2025
The wait is almost over! Our MMRF Patient Summit, in partnership with @hackensackmeridian.bsky.social is happening TOMORROW. If you can’t make it in-person you can join virtually at 9am ET. Register now so you don’t miss out: event.webcasts.com/starthere.js...
012
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 24/04/2025
Healthcare professionals, earn your credit today! In this CME-accredited activity, #myeloma experts discuss recent updates in the treatment landscape and practical strategies that may be implemented with patients in your community practice. 🎓 Get started: d.answersincme.com/160203256_2/...
d.answersincme.com
MDADI
MDADI
032
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 23/04/2025
In ONE week join us to learn about how CAR T-cell therapy works, how it's given to patients, and key side effects to be aware of. You’ll have the chance to ask questions & get answers directly from top #myeloma experts during a Q&A session. Register today: event.webcasts.com/starthere.js...
031
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 21/04/2025
Myeloma is the 2nd most common blood cancer overall & the most common blood cancer in the Black community. During #NationalMinorityCancerAwarenessWeek, let’s raise awareness of this rare blood cancer. To learn more about #myeloma, visit: themmrf.org/multiple-mye...
062
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 18/04/2025
🚨 Secure your spot for our informative & interactive MMRF Patient Summit in partnership with @hackensackmeridian.bsky.social. Discover the latest treatment strategies for newly diagnosed & relapsed/refractory #myeloma, managing symptoms & side effects, and more: event.webcasts.com/starthere.js...
022
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 18/04/2025
Save the date! 📅 You’re invited to a one-hour webinar where we’ll explain CAR T-cell therapy, a treatment approach that uses the power of your immune system to recognize and destroy #myeloma cells. Don’t miss out—register now: event.webcasts.com/starthere.js...
011
Multiple Myeloma Research Foundation (MMRF) @themmrf.bsky.social · 16/04/2025
Lisa wants to help other cancer patients by mentoring, sharing experiences, & offering resources, but most importantly helping them realize they are not alone. Our MMRF #Myeloma Mentors® are here for you. To schedule time with one of our mentors, visit: themmrf.org/support/myel...
021